39 results
6-K
TAK
Takeda Pharmaceutical Co
2 Feb 24
Current report (foreign)
6:16am
TAKHZYRO, with continued investment in lifecycle management programs. In rare hematology, Takeda focuses on addressing today’s needs in the treatment
6-K
TAK
Takeda Pharmaceutical Co
30 Oct 23
Current report (foreign)
6:02am
, including through TAKHZYRO, with continued investment in lifecycle management programs. In rare hematology, Takeda focuses on addressing today’s needs
6-K
TAK
Takeda Pharmaceutical Co
1 Aug 23
Current report (foreign)
6:10am
, Takeda aspires to transform the treatment paradigm, including through TAKHZYRO, with continued investment in lifecycle management programs. In rare
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
6 Jul 23
Current report (foreign)
6:18am
from the start. This program works to embed sustainability considerations into our decision-making for all aspects of a product’s lifecycle. It also … framework, we are integrating processes and building strategies to minimize lifecycle environmental impacts of our products, including supporting our net
6-K
EX-99.1
4esm7tn9e1j hat9vn4v
23 Jun 23
Current report (foreign)
6:13am
6-K
EX-99.1
3yjie2o27 rj
30 May 23
Current report (foreign)
6:11am
6-K
bqm5g4gbi3 ohn3
4 Nov 22
Current report (foreign)
6:01am
6-K
7mxmur
4 Aug 22
Current report (foreign)
6:07am
6-K
EX-99.1
f6921ov
31 May 22
Current report (foreign)
6:14am
6-K
EX-99.1
2jtuipqapnipqrk
31 May 22
Current report (foreign)
6:07am
6-K
mu5wjn3hm8lzmtzh
11 May 22
Current report (foreign)
6:06am
6-K
0617udcnelu
10 Feb 22
Current report (foreign)
6:03am
6-K
EX-99.1
0hngf4
11 Jan 22
Current report (foreign)
6:02am
6-K
j9j895 98v5992
5 Nov 21
Current report (foreign)
6:02am
6-K
2w6 6byi35dxyr
6 Aug 21
Current report (foreign)
6:06am
6-K
EX-99.1
ht05uw5msrfg ogs8
29 Jun 21
Current report (foreign)
7:38am
6-K
EX-99.1
49s7xrlpyf5ow4lg 1z
28 May 21
Current report (foreign)
6:01am